In 1992, Romach and colleagues noted that dose escalation is not a characteristic of extended-term alprazolam users and that almost all of very long-expression alprazolam customers change their First pattern of standard use to 1 of symptom Regulate only when required.[74]"There needs to be a procedure set up to ensure it will not reach some extent